» Articles » PMID: 33053675

Analytical Sensitivity and Specificity of Two RT-qPCR Protocols for SARS-CoV-2 Detection Performed in an Automated Workflow

Overview
Journal Genes (Basel)
Publisher MDPI
Date 2020 Oct 15
PMID 33053675
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

WHO declared the novel coronavirus (COVID-19) outbreak a global pandemic on 11 March 2020. The establishment of standardized RT-qPCR protocols for respiratory secretions testing, as well as sharing of specimens, data, and information became critical. Here, we investigate the analytical performance of two interim RT-qPCR protocols (Charité and Centers for Disease Control (CDC)) for the qualitative detection of SARS-CoV-2 executed in a fully automated platform. Analytical specificity, PCR amplification efficiency, analytical sensitivity (limit of detection), and cross-reactivity were evaluated using contrived samples. The on-going accuracy was evaluated by retrospective analysis of our test results database (real clinical samples). N1, E, and a modified version of RdRP assays presented adequate analytical specificity, amplification efficiency, and analytical sensitivity using contrived samples. The three assays were applied to all individuals who requested the SARS-CoV-2 molecular test assay in our laboratory and it was observed that N1 gave more positive results than E, and E gave more positive results than RdRP (modified). The RdRP and E were removed from the test and its final version, based on N1 assay only, was applied to 30,699 Brazilian individuals (from 19 February 2020 to 8 May 2020). The aggregated test results available in the database were also presented.

Citing Articles

An integrated methodological framework for the validation and verification of clinical testing by qRT-PCR.

Cardona-Ramirez C, Enriquez-Valencia C, Mendez-Callejas G, Barreto G, Tafur-Gomez G, Sanjuanelo-Corredor D Heliyon. 2025; 11(1):e41088.

PMID: 39801958 PMC: 11721250. DOI: 10.1016/j.heliyon.2024.e41088.


Extraction-Free Testing for SARS-CoV-2 in Nasal Swab and Saliva Samples on a Single High-Throughput Platform.

Qiu Y, Lu L, Halven A, Terrio R, Yuldelson S, Dougal N J Biotechnol Biomed. 2024; 7(2):214-220.

PMID: 39086601 PMC: 11290348. DOI: 10.26502/jbb.2642-91280144.


No Evidence of SARS-CoV-2 Infection in Wild Mink ( and ) from Northern Spain during the First Two Years of Pandemic.

Villanueva-Saz S, Giner J, Palomar A, Gomez M, Podra M, Del Carmen Aranda M Animals (Basel). 2022; 12(15).

PMID: 35953960 PMC: 9367499. DOI: 10.3390/ani12151971.


SARS-CoV-2 Brain Regional Detection, Histopathology, Gene Expression, and Immunomodulatory Changes in Decedents with COVID-19.

Serrano G, Walker J, Tremblay C, Piras I, Huentelman M, Belden C J Neuropathol Exp Neurol. 2022; 81(9):666-695.

PMID: 35818336 PMC: 9278252. DOI: 10.1093/jnen/nlac056.


SARS-CoV-2 Diagnostics Based on Nucleic Acids Amplification: From Fundamental Concepts to Applications and Beyond.

Vindeirinho J, Pinho E, Azevedo N, Almeida C Front Cell Infect Microbiol. 2022; 12:799678.

PMID: 35402302 PMC: 8984495. DOI: 10.3389/fcimb.2022.799678.


References
1.
Lippi G, Simundic A, Plebani M . Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19). Clin Chem Lab Med. 2020; 58(7):1070-1076. DOI: 10.1515/cclm-2020-0285. View

2.
Kim D, Lee J, Yang J, Kim J, Kim V, Chang H . The Architecture of SARS-CoV-2 Transcriptome. Cell. 2020; 181(4):914-921.e10. PMC: 7179501. DOI: 10.1016/j.cell.2020.04.011. View

3.
Lai C, Shih T, Ko W, Tang H, Hsueh P . Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020; 55(3):105924. PMC: 7127800. DOI: 10.1016/j.ijantimicag.2020.105924. View

4.
Kravchenko A, Chetverina E, Chetverin A . [Retention of nucleic acid integrity in guanidine thiocyanate lysates of whole blood]. Bioorg Khim. 2006; 32(6):609-14. DOI: 10.1134/s1068162006060070. View

5.
Lu X, Wang L, Sakthivel S, Whitaker B, Murray J, Kamili S . US CDC Real-Time Reverse Transcription PCR Panel for Detection of Severe Acute Respiratory Syndrome Coronavirus 2. Emerg Infect Dis. 2020; 26(8). PMC: 7392423. DOI: 10.3201/eid2608.201246. View